Analytical testing – Our team conducts a series of scientific assessments to ensure the quality, safety, and efficacy of the materials used in clinical trials.
Applied Clinical Trial Materials
Bringing successful drugs to market is more difficult than ever before. With increasingly condensed timelines and more complex drug chemistries, drug development teams are feeling the pressure to provide safe, effective products.
Therefore, it’s no surprise that many drug developers rely on contract development and manufacturing organizations (CDMOs) to ensure their pharmaceutical projects are brought to market in a timely and cost-effective manner. Ascendia Pharmaceutical Solutions is often the Partner of Choice for pharmaceutical companies due to our ability to provide drug development teams with effective, efficient production of clinical trial materials (CTM).
The importance of high-quality CTM
Phase I clinical trials are an exciting time for drug development teams – their investigational drug formulation will finally be used in human subjects for the first time. Therefore, producing CTM to the highest quality standard is of the utmost importance. Manufacturers must adhere to GMP/cGMP regulations throughout the process – from formulation through packaging – to provide developers with safe, consistent CTM for use. Failure to adhere to these regulations can be costly, both in the resources required to remedy inconsistent results through repeated studies, as well as in the time lost.
It’s imperative that pharmaceutical companies partner with trusted CDMOs with the proven ability to adhere to all applicable regulations and best practices. It is the best way to be assured their clinical trials will produce repeatable, accurate data.
An Integrated, one-source solution for CTM
Ascendia’s experienced team of scientists is knowledgeable in a variety of dosage forms, including oral, parenteral, transdermal, and ophthalmic. In fact, Ascendia has often been proven being able to develop a novel dosage form where others have failed.
We utilize our proprietary nanotechnologies to aid in the formulation development of poorly soluble, low bioavailability drugs. Our GMP/cGMP-compliant facility meets the supply needs of Phase I, Phase II, and Phase III clinical trials, providing clients with high quality CTM for their efficacy and safety testing.
In addition to meeting FDA guidelines in all CTM processes, we maintain chambers for conducting stability testing, in accordance with International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines. Clients can be confident that the characteristics and performance of each batch of CTM will be replicated consistently all the way through to commercialization.
Ascendia offers the following services for early-stage and late stage development of CTM:
Raw material characterization and sourcing – Our expert team thoroughly evaluates the physical and chemical properties of all raw materials, while also identifying and selecting reliable suppliers.
Cleaning development and validation – Our documented process ensures the manufacturing equipment is thoroughly cleaned to guarantee the safety and efficacy of the trial drug.
Formulation development – We use our nanotechnologies to design and create the specific drug form to ensure it is stable, safe, and delivers the desired dose to participants while considering the route of administration and patient acceptability.
Pilot batch manufacturing – We conduct a small-scale production run before full-scale clinical trial production to test and optimize the manufacturing process and assess product quality.
Scale-up – Finally, we increase the production volume of a drug substance or drug product from a small laboratory scale to larger manufacturing scale.
Method development and validation – Our process creates and scientifically proves that our analytical method is suitable to accurately measure the concentration of a drug substance or product within clinical trial samples. The result is reliable and consistent results.
GMP batch manufacturing – We strictly adhere to GMP/cGMP guidelines, ensuring consistent quality, safety, and efficacy of the drug throughout the manufacturing process.
GMP release testing with QC release - Quality control tests according to GMP/cGMP standards are performed and certified by QA.
Keeping Projects Moving Forward
Ascendia knows that time is of the essence when bringing drugs to market. We pride ourselves on our ability to move projects down the development pipeline efficiently. The Ascendia team prioritizes effective communication with clients, keeping them informed every step of the way.
With 10+ years of experience as a CDMO, Ascendia understands how to effectively plan, resource, and execute successful CTM projects. We remain flexible so that any unforeseen challenges can be addressed and mitigated in collaboration with the client.
Reach Out to Learn More
Ascendia has the knowledge and experience needed to create successful partnerships with drug developers across the globe. Reach out today to learn how Ascendia’s custom-tailored solutions can get your product market-ready.